"Procter "
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
You Might Like
UK: Healthcare M&A And Financing Trends And Predictions For 2024 - Goodwin Procter LLPThe healthcare sector was one of the biggest beneficiaries of the pandemic influenced boom in asset values, but has faced significant headwinds since the middle of 2022.Mondaq - Published | |
European Union: The European Parliament Adopts Position On The European Commission's Proposal For The First Major Overhaul Of The EU Medicines Regulatory Framework In 20 Years - Goodwin Procter LLPIn April 2023, we published an alert in relation to two European Commission legislative proposals: new Regulation 2023/0131 and new Directive 2023/0132...Mondaq - Published | |
3 New Reasons to Like This Magnificent Dividend StockProcter & Gamble just hiked its dividend for the 68th consecutive year.Motley Fool - Published | |
United States: DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing - Goodwin Procter LLPAs we previously reported, the U.S. Department of Justice ("DOJ") filed a lawsuit under the Anti-Kickback Statute against Regeneron Pharmaceuticals in the District of Massachusetts...Mondaq - Published | |
United States: Kansas Becomes Fourth State To Enact Law Regulating Earned Wage Access Services - Goodwin Procter LLPKansas has become the fourth state (and the second in 2024) to enact a law that establishes a financial services oversight regime for earned wage access services...Mondaq - Published | |
United States: FDA Approval Of Alvotech/Teva Ustekinumab Biosimilar - Goodwin Procter LLPOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson's STELERA® (ustekinumab).Mondaq - Published | |
